Suppr超能文献

Tsc2-Rheb 信号调节 EphA 介导的轴突导向。

Tsc2-Rheb signaling regulates EphA-mediated axon guidance.

机构信息

The F.M. Kirby Neurobiology Center, Department of Neurology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Nat Neurosci. 2010 Feb;13(2):163-72. doi: 10.1038/nn.2477. Epub 2010 Jan 10.

Abstract

Tuberous sclerosis complex is a disease caused by mutations in the TSC1 or TSC2 genes, which encode a protein complex that inhibits mTOR kinase signaling by inactivating the Rheb GTPase. Activation of mTOR promotes the formation of benign tumors in various organs and the mechanisms underlying the neurological symptoms of the disease remain largely unknown. We found that Tsc2 haploinsufficiency in mice caused aberrant retinogeniculate projections that suggest defects in EphA receptor-dependent axon guidance. We also found that EphA receptor activation by ephrin-A ligands in neurons led to inhibition of extracellular signal-regulated kinase 1/2 (ERK1/2) activity and decreased inhibition of Tsc2 by ERK1/2. Thus, ephrin stimulation inactivates the mTOR pathway by enhancing Tsc2 activity. Furthermore, Tsc2 deficiency and hyperactive Rheb constitutively activated mTOR and inhibited ephrin-induced growth cone collapse. Our results indicate that TSC2-Rheb-mTOR signaling cooperates with the ephrin-Eph receptor system to control axon guidance in the visual system.

摘要

结节性硬化症是一种由 TSC1 或 TSC2 基因突变引起的疾病,这些基因编码一种蛋白复合物,通过使 Rheb GTP 酶失活来抑制 mTOR 激酶信号传导。mTOR 的激活促进了各种器官中良性肿瘤的形成,而疾病的神经学症状的潜在机制在很大程度上仍然未知。我们发现,小鼠中 Tsc2 的杂合不足导致了视网膜神经节投射的异常,提示 EphA 受体依赖性轴突导向存在缺陷。我们还发现,神经元中 EphA 受体激活 Ephrin-A 配体导致细胞外信号调节激酶 1/2(ERK1/2)活性的抑制和 ERK1/2 对 Tsc2 的抑制减少。因此,Ephrin 刺激通过增强 Tsc2 活性使 mTOR 途径失活。此外,Tsc2 缺失和活性过高的 Rheb 持续激活 mTOR 并抑制 Ephrin 诱导的生长锥塌陷。我们的结果表明,TSC2-Rheb-mTOR 信号与 Ephrin-Eph 受体系统合作,控制视觉系统中的轴突导向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a8/2812631/6e5aa76fb99f/nihms165636f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验